Matrix metalloproteinases (MMPs) degrade the extracellular matrix and carry out key functions during development and after injury. By means of zymography, Western blot and immunohistochemistry, we studied MMP-2 (gelatinase A) and MMP-9 (gelatinase B) in rat brain after focal cerebral ischemia. The control rat brain showed constitutive MMP-2 and, to a lesser extent, MMP-9, which were mainly present as prozymogens. MMP-2 protein was located in the cell body of neurons, glia, and endothelium, whereas MMP-9 was associated to neurons and myelinated fibre tracts. Ischemia greatly increased MMP activation in two temporal waves, in the first one, MMP-9 protein was induced from 4 h to 4 days, and also a small and short-lasting increase in MMP-2 was detected at 4 h. The second wave showed a massive increase in MMP-2 protein expression and activation by day 4, which was compatible with abundant MMP-2 in reactive microglia/macrophages. Our results are compatible with progressive induction of MMP-9 proform, likely in neurons, shortly after ischemia. For MMP-2, the results suggest a discrete production immediately after reperfusion, while a very enhanced expression and activation of MMP-2 attributable to microglia/macrophages occurs on day 4, and it might contribute to the phagocytic action of these reactive cells.
INTRODUCTION
A complex macromolecular network known as the extracellular matrix occupies the extracellular space. This matrix is composed of a variety of polysaccharides and proteins and it is strongly associated with the cell surface. In conjunctive tissue, the extracellular matrix occupies a larger space than that of cells, whereas in brain, the matrix is mainly developed as the basal lamina surrounding blood vessels. Local cells normally produce the extracellular matrix components and therefore the composition of the matrix is dependent on the cellular environment. Members of a family of enzymes named matrix metalloproteinases (MMPs) become active and degrade components of the extracellular matrix following injury and in a variety of pathologies. MMP-2 and MMP-9, also known as gelatinase A and B, respectively, because of their ability to degrade gelatin, have important functions during the development of the nervous system (Romanic & Madri, 1994; Canete Soler et al., 1995; Vaillant et al., 1999) , particularly during myelination, as MMP-9 mediates oligodendrocyte process outgrowth (Uhm et al., 1998) , and oligodendrocytes in culture secrete MMP-9 and express active cell-associated gelatinases at the growing tips of their processes (Oh et al., 1999) .
MMP-2 and MMP-9 are normally found as latent zymogens, which have a physically hidden active site, and thus they cannot access substrates. These latent forms found in vivo can be experimentally activated in vitro with compounds such as organomercurials (Davies & Martin, 1990; Springman et al., 1990; Ogata et al., 1995) . Proenzymes have a greater molecular weight than the active forms and, in addition, form complexes with inhibitory proteins such as those of the family of tissue inhibitor of metalloproteinases (TIMP) (Howard et al., 1991; Ogata et al., 1995) . The proforms become
